Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INTUITIVE SURGICAL, INC.

(ISRG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Intuitive Surgical Names Executives for Strategy and Growth, Global Business Services

10/19/2021 | 03:25pm EST

By Michael Dabaie

Intuitive Surgical Inc. unveiled executive leadership changes for Strategy and Growth and for Global Business Services, two new organizations within the company.

The company said Chief Financial Officer Marshall Mohr will assume the new role of executive vice president of global business services on Jan. 1.

Jamie Samath, who has been with Intuitive since 2013, will succeed Mr. Mohr to become CFO.

In his new role, Mr. Mohr will lead Intuitive's growth in infrastructure, processes, and systems and facilities, the technology company in minimally invasive care and robotic-assisted surgery said. He has served as CFO for more than 15 years

Intuitive said it has created two new functional organizations: Strategy and Growth, and Global Business Services.

Dave Rosa will take the new role of executive vice president and chief strategy and growth officer, leading efforts to identify and realize long-term business opportunities. Mr. Rosa has been with Intuitive for more than 25 years, working across the business.

Henry Charlton will succeed Mr. Rosa in the role of chief commercial officer, overseeing global sales, regional marketing, commercial learning and enablement, and services. He has been with Intuitive for 18 years in the commercial organization.

"These are outstanding and proven leaders. I am confident they will be effective in pursuing our goal to advance minimally invasive care globally in a highly competitive environment," said Intuitive CEO Gary Guthart. "Their efforts will help us operate at the larger scale our customers demand globally."

Write to Michael Dabaie at michael.dabaie@wsj.com

(END) Dow Jones Newswires

10-19-21 1524ET

All news about INTUITIVE SURGICAL, INC.
11/29INSIDER SELL : Intuitive Surgical
MT
11/22Intuitive Announces Executive Leadership Changes
AQ
10/21INTUITIVE SURGICAL : Morgan Stanley Adjusts Price Target on Intuitive Surgical to $325 fro..
MT
10/20INTUITIVE SURGICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
AQ
10/20Tranche Update on Intuitive Surgical, Inc.'s Equity Buyback Plan announced on February ..
CI
10/20INTUITIVE SURGICAL : Wells Fargo Adjusts Intuitive Surgical's Price Target to $381 from $3..
MT
10/20INTUITIVE SURGICAL : UBS Adjusts Price Target on Intuitive Surgical to $352 From $323 on I..
MT
10/20INTUITIVE SURGICAL : Deutsche Bank Adjusts Intuitive Surgical PT to $323 From $306, Mainta..
MT
10/19Intuitive Surgical 3Q Beats Analyst Views
DJ
10/19Intuitive Surgical Names Executives for Strategy and Growth, Global Business Services
DJ
More news
Analyst Recommendations on INTUITIVE SURGICAL, INC.
More recommendations
Financials (USD)
Sales 2021 5 676 M - -
Net income 2021 1 661 M - -
Net cash 2021 2 642 M - -
P/E ratio 2021 72,2x
Yield 2021 -
Capitalization 115 B 115 B -
EV / Sales 2021 19,8x
EV / Sales 2022 17,1x
Nbr of Employees 8 081
Free-Float 99,0%
Chart INTUITIVE SURGICAL, INC.
Duration : Period :
Intuitive Surgical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INTUITIVE SURGICAL, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 321,63 $
Average target price 349,00 $
Spread / Average Target 8,51%
EPS Revisions
Managers and Directors
Gary S. Guthart President, Chief Executive Officer & Director
Marshall L. Mohr Chief Financial Officer & Executive Vice President
Calvin Darling Senior Director-Finance & Investor Relations
Craig H. Barratt Chairman
Myriam J. Curet Chief Medical Officer & Executive Vice President
Sector and Competitors